Rare diseases
Investigational molecules
Locations
469 conditions with trials, the busiest first
1 123 trials across Europe, recruiting first
Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
CzechiaStudy on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer
BelgiumStudy of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn's Disease
BelgiumStudy on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis
AustriaStudy on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease
BulgariaStudy on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
AustriaStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis
GermanyStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
AustriaThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
